Researcher.Life Logo

Frontiers in Molecular Neuroscience : Impact Factor & More

eISSN: 1662-5099pISSN: 1662-5099
JournalOpen Access

Key Metrics

CiteScore
9.3
Eigenfactor
0.01 - 0.05
Impact Factor
< 5
Scite Index
0.92 5-Year SI
SJR
Q1Molecular Biology
SNIP
1.33
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Frontiers in Molecular Neuroscience

Frontiers in Molecular Neuroscience Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher FRONTIERS MEDIA SA
Language English
Frequency Continuous publication
Article Processing ChargesUSD 2950
Publication Time14
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2008
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 14
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY
OA statementVisit website
View less

Planning to publish in Frontiers in Molecular Neuroscience ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Frontiers in Molecular Neuroscience

Analyses of exon 4a structure reveal the properties of Big tau related to distribution, function and aggregation
  • 28 Oct 2025
  • Frontiers in Molecular Neuroscience
Transcriptomic profiling of neural cultures from the KYOU iPSC line via alternative differentiation protocols
  • 28 Oct 2025
  • Frontiers in Molecular Neuroscience
Bridging prion biology and Alzheimer’s disease: from pathogenic seeds to precision therapeutics
  • 22 Oct 2025
  • Frontiers in Molecular Neuroscience
Beyond cell-cell contact: therapeutic potential of Eph signaling in central nervous system tumors
  • 22 Oct 2025
  • Frontiers in Molecular Neuroscience
Targeting ER stress in skeletal muscle through physical activity: a strategy for combating neurodegeneration-associated muscle decline
  • 21 Oct 2025
  • Frontiers in Molecular Neuroscience
Lysine α-ketoglutarate reductase as a therapeutic target for saccharopine pathway related diseases
  • 21 Oct 2025
  • Frontiers in Molecular Neuroscience
Analyses of exon 4a structure reveal the properties of Big tau related to distribution, function and aggregation
  • 28 Oct 2025
  • Frontiers in Molecular Neuroscience
Transcriptomic profiling of neural cultures from the KYOU iPSC line via alternative differentiation protocols
  • 28 Oct 2025
  • Frontiers in Molecular Neuroscience
Bridging prion biology and Alzheimer’s disease: from pathogenic seeds to precision therapeutics
  • 22 Oct 2025
  • Frontiers in Molecular Neuroscience
Beyond cell-cell contact: therapeutic potential of Eph signaling in central nervous system tumors
  • 22 Oct 2025
  • Frontiers in Molecular Neuroscience
Targeting ER stress in skeletal muscle through physical activity: a strategy for combating neurodegeneration-associated muscle decline
  • 21 Oct 2025
  • Frontiers in Molecular Neuroscience
Lysine α-ketoglutarate reductase as a therapeutic target for saccharopine pathway related diseases
  • 21 Oct 2025
  • Frontiers in Molecular Neuroscience

FAQs on Frontiers in Molecular Neuroscience